This Week at FDA: mRNA boosters for most; Blood lancets reclassified

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesDiagnostics/IVDsMedical DevicesNorth AmericaOTCPharmaceuticals